CPCM
EVFM

Clifton Park Capital Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Clifton Park Capital Management’s Portfolio EVFM Stock Details EVFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$869K Hold
6,944
– – 0.1% 16
2015
Q3 		$5.04M Sell
6,944
-612
-8% -$657K 0.45% 17
2015
Q2 		$6.12M Sell
7,556
-1,573
-17% -$1.01M 0.45% 19
2015
Q1 		$6.75M Buy
+9,129
New +$5.83M 0.41% 23

Other funds holding EVFM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Clifton Park Capital Management's EVFM Position: Q4 2015 in Review

Clifton Park Capital Management held its Evofem Biosciences, Inc. Common Stock (EVFM) position steady in Q4 2015 at 6,944 shares worth $869K. The position accounts for 0.1% of the portfolio, ranked #16.

Clifton Park Capital Management first reported a position in EVFM in Q1 2015 and has held it in 4 quarters since. The position peaked at $6.75M in Q1 2015. 24 funds tracked by Wall St. Rank hold EVFM as of Q4 2015.

  • Clifton Park Capital Management held 6,944 shares of Evofem Biosciences, Inc. Common Stock worth $869K as of Q4 2015.
  • Clifton Park Capital Management left its Evofem Biosciences, Inc. Common Stock share count unchanged in Q4 2015.
  • Evofem Biosciences, Inc. Common Stock made up 0.1% of Clifton Park Capital Management's portfolio in Q4 2015, its #16 holding.
  • Clifton Park Capital Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q1 2015 and has held it in 4 quarters since.
  • Clifton Park Capital Management's Evofem Biosciences, Inc. Common Stock position peaked at $6.75M in Q1 2015.
  • 24 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2015.

Based on Clifton Park Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.